Mayne Pharma dodges questions about financial performance

MELBOURNE: Mayne Pharma, which is enmeshed in a court battle with former suitor ... read more

Media company now pays 16.2 per cent dividend

MELBOURNE: A media company has paid an 11 per cent dividend for 22 ... read more

Blackstone agrees sale of CMAX Clinical Research to pacify ACCC

SYDNEY: One of Australia’s longest-running providers of phase-1 clinical trials for drug developers ... read more

Regal-backed biotech to ASX, promises Alpine Capital executives

MELBOURNE: Nexsen, a biotech that’s aiming to be at the forefront of rapid ... read more